"PERSISTENT POST-COVID IMMUNOSUPPRESSION AND HEALTHCARE- ASSOCIATED INFECTIONS - POSSIBLE MECHANISMS AND IMPLICATIONS IN MULTIDRUG-RESISTANT INFECTIONS"

E. Toma, Adriana Nicoleta Trandafir, O. Enciu
{"title":"\"PERSISTENT POST-COVID IMMUNOSUPPRESSION AND HEALTHCARE- ASSOCIATED INFECTIONS - POSSIBLE MECHANISMS AND IMPLICATIONS IN MULTIDRUG-RESISTANT INFECTIONS\"","authors":"E. Toma, Adriana Nicoleta Trandafir, O. Enciu","doi":"10.54044/rami.2022.03.08","DOIUrl":null,"url":null,"abstract":"One of the main concerns of the medical community during the COVID-19 pandemic has been the management of the immunosuppression accompanying the disease, particularly in ICU (Intensive Care Unit) patients. More recently, the focus has shifted towards the management of the persistent immunosuppression post-acute COVID-19 and its complications. The rate of healthcare-associated infections (HAIs) had been declining before the pandemic, but has since started to increase once more. Due to multiple factors – unnecessary antibiotherapy, disorganized medical facilities, inadequate personal protection equipment etc. – there have been increasing reports of coinfections and secondary infections with multidrug-resistant bacteria in COVID-19 patients. We present a case report of a patient with no history of clinically overt immunosuppression before developing critical SARS-CoV-2 pneumonia. The patient had no need for antibiotic treatment during his hospitalization and was discharged in a stable state, being consequently readmitted multiple times for different healthcare-associated multidrug-resistant infections, over time developing other hospital-related complications. The case raises a discussion about the bidirectional relationship between post-COVID immunosuppression and the possible inadvertent excess in antibiotic therapy that has accompanied the pandemic.","PeriodicalId":237638,"journal":{"name":"Romanian Archives of Microbiology and Immunology","volume":"7 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Romanian Archives of Microbiology and Immunology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.54044/rami.2022.03.08","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

One of the main concerns of the medical community during the COVID-19 pandemic has been the management of the immunosuppression accompanying the disease, particularly in ICU (Intensive Care Unit) patients. More recently, the focus has shifted towards the management of the persistent immunosuppression post-acute COVID-19 and its complications. The rate of healthcare-associated infections (HAIs) had been declining before the pandemic, but has since started to increase once more. Due to multiple factors – unnecessary antibiotherapy, disorganized medical facilities, inadequate personal protection equipment etc. – there have been increasing reports of coinfections and secondary infections with multidrug-resistant bacteria in COVID-19 patients. We present a case report of a patient with no history of clinically overt immunosuppression before developing critical SARS-CoV-2 pneumonia. The patient had no need for antibiotic treatment during his hospitalization and was discharged in a stable state, being consequently readmitted multiple times for different healthcare-associated multidrug-resistant infections, over time developing other hospital-related complications. The case raises a discussion about the bidirectional relationship between post-COVID immunosuppression and the possible inadvertent excess in antibiotic therapy that has accompanied the pandemic.
“持续的covid后免疫抑制和保健相关感染——耐多药感染的可能机制和影响”
在COVID-19大流行期间,医学界关注的主要问题之一是对伴随疾病的免疫抑制的管理,特别是对ICU(重症监护病房)患者。最近,重点已转向对COVID-19急性期后持续免疫抑制及其并发症的管理。在大流行之前,卫生保健相关感染率一直在下降,但此后又开始上升。由于不必要的抗生素治疗、医疗设施混乱、个人防护装备不足等多种因素,COVID-19患者中合并感染和继发感染的报告越来越多。我们报告了一例在发生严重的SARS-CoV-2肺炎之前没有临床明显免疫抑制史的患者。该患者在住院期间无需抗生素治疗,出院时状态稳定,随后因不同的医疗保健相关耐多药感染多次再次入院,随着时间的推移出现了其他与医院相关的并发症。该病例引发了关于covid后免疫抑制与伴随大流行的抗生素治疗可能无意过量之间的双向关系的讨论。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信